Search

everythinglearnresearchcommunity

for

Search:↓

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Stem cells help remove dead cells to keep tissues healthy by balancing cell replacement and clearance.

Bezafibrate treatment improved skin and spleen health in aging mice but didn't extend lifespan.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Defective mitochondrial DNA replication causes aging symptoms and increased oxidative damage in mice.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Brazilian propolis was found to speed up hair growth in mice by increasing the growth of skin cells that form hair.

Low humidity changes skin gene expression, but emollients can help manage these changes.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Fat-related cells are important for initiating hair growth.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

MED1 affects skin wound healing differently in young and old mice.

New culture method keeps human skin stem cells more stem-like.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.